Genenta Science S.p.A. Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value
Genenta Science S.p.A. (GNTA) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value of 5.3 EUR/shares for the 6-month period ending 2024-06-30, per its 6-K filed 2024-10-29.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue · last filed 2024-10-29
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value 6 month as first filed | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value 12 month as first filed |
|---|---|---|---|---|
| 2024-06-30 | 5.30 EUR/shares 6-K · filed 2024-10-29 | |||
| 2023-12-31 | 4.84 EUR/shares 20-F · filed 2024-03-29 | |||
| 2023-06-30 | 5.30 EUR/shares 6-K · filed 2023-10-20 | |||
| 2022-06-30 | 6.38 EUR/shares 6-K · filed 2023-10-20 | 1.62 EUR/shares 6-K · filed 2022-10-25 | ||
| 2021-12-31 | 4.99 EUR/shares 20-F · filed 2024-03-29 | 1.09K EUR/shares 20-F · filed 2022-05-02 | ||
| 2021-06-30 | 1.09K EUR/shares 6-K · filed 2022-10-25 | |||
| 2020-12-31 | 0.00 EUR/shares 20-F · filed 2023-04-21 | |||
| 2019-12-31 | 1.09K EUR/shares 20-F · filed 2022-05-02 |